Research programme: small molecule therapeutics - Torrent Pharmaceuticals

Drug Profile

Research programme: small molecule therapeutics - Torrent Pharmaceuticals

Alternative Names: DARA - Torrent Pharmaceuticals; HIF; TRC 160334

Latest Information Update: 26 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Torrent Pharmaceuticals
  • Class Antihyperglycaemics; Antihypertensives; Heterocyclic compounds; Small molecules; Urologics
  • Mechanism of Action Angiotensin type 2 receptor antagonists; Endothelin A receptor antagonists; Hypoxia-inducible factor-proline dioxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Acute kidney injury; Asthma; Chronic obstructive pulmonary disease; Hypertension
  • Research Atopic dermatitis; Diabetes mellitus

Most Recent Events

  • 26 Jun 2018 Early research in Atopic dermatitis in India (unspecified route) (Torrent Pharma pipeline, June 2018)
  • 26 Jun 2018 Preclinical trials in Asthma in India (unspecified route) (Torrent Pharma pipeline, June 2018)
  • 26 Jun 2018 Preclinical trials in Chronic obstructive pulmonary disease in India (unspecified route) (Torrent Pharma pipeline, June 2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top